Atkinson V - Search Results

1

BRAFV600E mutation status of involuting and stable nevi in dabrafenib therapy with or without trametinib.

McClenahan P, Lin LL, Tan JM, Flewell-Smith R, Schaider H, Jagirdar K, Atkinson V, Lambie D, Prow TW, Sturm RA, Soyer HP. McClenahan P, et al. Among authors: atkinson v. JAMA Dermatol. 2014 Oct;150(10):1079-82. doi: 10.1001/jamadermatol.2014.436. JAMA Dermatol. 2014. PMID: 24695877

2

Radiotherapy utilization in BRAF mutation-tested metastatic melanoma in the targeted therapy era.

Gorayski P, Dzienis M, Foote M, Atkinson V, Burmeister E, Burmeister B. Gorayski P, et al. Among authors: atkinson v. Asia Pac J Clin Oncol. 2017 Apr;13(2):e117-e123. doi: 10.1111/ajco.12345. Epub 2015 Apr 13. Asia Pac J Clin Oncol. 2017. PMID: 25865802

3

A case of acute paraneoplastic neurological syndrome in BRAF mutant metastatic melanoma.

Lee SF, Atkinson V. Lee SF, et al. Among authors: atkinson v. Melanoma Res. 2016 Aug;26(4):425-8. doi: 10.1097/CMR.0000000000000264. Melanoma Res. 2016. PMID: 27138260

4

Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists.

Atkinson V, Long GV, Menzies AM, McArthur G, Carlino MS, Millward M, Roberts-Thomson R, Brady B, Kefford R, Haydon A, Cebon J. Atkinson V, et al. Asia Pac J Clin Oncol. 2016 Dec;12 Suppl 7:5-12. doi: 10.1111/ajco.12656. Asia Pac J Clin Oncol. 2016. PMID: 27905182

5

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.

Long GV, Hauschild A, Santinami M, Atkinson V, Mandalà M, Chiarion-Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Schachter J, Schadendorf D, Lesimple T, Plummer R, Ji R, Zhang P, Mookerjee B, Legos J, Kefford R, Dummer R, Kirkwood JM. Long GV, et al. Among authors: atkinson v. N Engl J Med. 2017 Nov 9;377(19):1813-1823. doi: 10.1056/NEJMoa1708539. Epub 2017 Sep 10. N Engl J Med. 2017. PMID: 28891408 Free article. Clinical Trial.

6

Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1.

Thomas S, Laino A, Sturm R, Nufer K, Lambie D, Shepherd B, Atkinson V, Adams L, Soyer HP, Schaider H. Thomas S, et al. Among authors: atkinson v. J Eur Acad Dermatol Venereol. 2018 May;32(5):e176-e177. doi: 10.1111/jdv.14678. Epub 2017 Dec 1. J Eur Acad Dermatol Venereol. 2018. PMID: 29114959 No abstract available.

7

Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS-Mutant Cancers.

Hammerlindl H, Ravindran Menon D, Hammerlindl S, Emran AA, Torrano J, Sproesser K, Thakkar D, Xiao M, Atkinson VG, Gabrielli B, Haass NK, Herlyn M, Krepler C, Schaider H. Hammerlindl H, et al. Clin Cancer Res. 2018 Mar 1;24(5):1090-1102. doi: 10.1158/1078-0432.CCR-16-2118. Epub 2017 Dec 1. Clin Cancer Res. 2018. PMID: 29196297 Free PMC article.

8

Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma.

Laino A, Shepherd B, Atkinson V, Fu H, Soyer HP, Schaider H. Laino A, et al. Among authors: atkinson v. JAAD Case Rep. 2018 Oct 10;4(9):921-923. doi: 10.1016/j.jdcr.2018.06.024. eCollection 2018 Oct. JAAD Case Rep. 2018. PMID: 30320196 Free PMC article. No abstract available.

9

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma.

Hauschild A, Dummer R, Schadendorf D, Santinami M, Atkinson V, Mandalà M, Chiarion-Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Schachter J, Lesimple T, Plummer R, Dasgupta K, Haas T, Shilkrut M, Gasal E, Kefford R, Kirkwood JM, Long GV. Hauschild A, et al. Among authors: atkinson v. J Clin Oncol. 2018 Dec 10;36(35):3441-3449. doi: 10.1200/JCO.18.01219. Epub 2018 Oct 22. J Clin Oncol. 2018. PMID: 30343620 Free PMC article. Clinical Trial.

10

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial.

Ascierto PA, Long GV, Robert C, Brady B, Dutriaux C, Di Giacomo AM, Mortier L, Hassel JC, Rutkowski P, McNeil C, Kalinka-Warzocha E, Savage KJ, Hernberg MM, Lebbé C, Charles J, Mihalcioiu C, Chiarion-Sileni V, Mauch C, Cognetti F, Ny L, Arance A, Svane IM, Schadendorf D, Gogas H, Saci A, Jiang J, Rizzo J, Atkinson V. Ascierto PA, et al. Among authors: atkinson v. JAMA Oncol. 2019 Feb 1;5(2):187-194. doi: 10.1001/jamaoncol.2018.4514. JAMA Oncol. 2019. PMID: 30422243 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters